Press Resease

Biopharmaceutical Excipients Market By Products (Specialty Excipients, Carbohydrates, Polyols, Solubilizers & Surfactants/Emulsifiers, and Others), By Function (lubricants & glidants, Preservatives, Disintegrants, Coatings, Binders, Pharmaceutical Fillers, and Others), By Application (Advanced Delivery System, Parenteral, Topical, and Oral): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 – 2028

Published Date: 16-Jun-2021 Category: Chemical & Materials Report Format : PDF Pages: 130 Report Code: ZMR-5639 Status : Published

The global Biopharmaceutical Excipients market accounted for USD 2.07 Billion in 2020 and is expected to reach USD 3.97 Billion by 2028, growing at a CAGR of 8.5% from 2021 to 2028.

Description

Market Overview

The global Biopharmaceutical Excipients market accounted for USD 2.07 Billion in 2020 and is expected to reach USD 3.97 Billion by 2028, growing at a CAGR of 8.5% from 2021 to 2028.

Biopharmaceutical excipients are macromolecular or cellular materials that are used in medicinal products such as blood and other genetically modified products. There are inert compounds that are mainly used as a carrier and do not have any therapeutic properties. To achieve the needed formulations, these are combined with other active pharmaceutical materials. It also increases the product's shelf life. Since biopharmaceuticals are very unstable molecules, they must be used with precision and care to obtain the necessary combination of excipients in order to enhance the combination's stability. They are used to change the colour, taste, binding capacity, elegancy, and release rate of active pharmaceutical ingredients, among other things. Emulsifier agents, diluent excipients, co-processed excipients, carrier agents, binding agents, and other stabilising substances are all widely used.

COVID-19 Impact Analysis

The outbreak of an infectious disease that caused a severe respiratory problem resulted in a surge in demand for macromolecules for treatment. The rising demand for these macromolecules necessitates biopharmaceutical excipients to improve stability and shelf life, which is expected to aid market growth in the near future. The pandemic has prompted major players to focus their efforts on developing genetically modified molecules for improved care of Covid-19 patients, which is expected to increase the use of pharmaceutical excipients in the immediate future.

Growth Factors

The major growth factors of Biopharmaceutical Excipients Market are: Supreme Properties of Biopharmaceutical Excipients, in recent years, the global demand for biopharmaceutical excipients has drawn substantial revenues. The capacity of biopharmaceutical excipients to have a degree of stability has been a major factor in the former's success. The presence of a unified pharmaceutical manufacturing industry is another development that has boosted the global market's growth trajectory.

Need for Improved Drug Delivery, the medical community has been emphasising the importance of developing new and improved drug lines. Biopharmaceutical excipients may be used to boost drug lines because they help to enhance the action of drugs. As a result, the global biopharmaceutical excipients market is expected to reach new heights in the coming years.

Report Scope:

Product Type Segment Analysis

Products Type segment are Specialty Excipients, Carbohydrates, Polyols, Solubilizers & Surfactants/Emulsifiers, and Others. Carbohydrate-based excipient products dominated the market, and this trend is expected to continue during the forecast period. The dominance of the segment can be traced to the widespread use of starch, sucrose, and dextrose in different drug formulations. In addition, the growing use of carbohydrates as bulking agents in the lyophilization of biomolecules like proteins is fuelling segment development.

Function Segment Analysis

Pharmaceutical excipients are classified as fillers & diluents, binders, suspending & viscosity agents, flavouring agents & sweeteners, coating agents, colourants, disintegrants, lubricants & glidants, preservatives, emulsifying agents, and other functionalities, depending on their functionality. Fillers and diluents had the largest share of the market in 2020, based on functionality. As fillers and diluents are used in the production of tablets and capsules, there is a strong demand for them.

Regional Segment Analysis

North America had the largest market share of 31.2% in 2020, thanks to a number of factors including the involvement of major players, increased opioid production, and a massive population base. Collaborations are taking place in this area to establish biopharmaceutical excipients. For example, ReForm Biologics LLC and MilliporeSigma collaborated in February 2020 to commercialise the company's proprietary excipients used in biotherapeutic formulations. MilliporeSigma will finance R&D and commercialise ReForm Biologics' excipients for drug production under the terms of the collaboration.

The Asia Pacific region is projected to grow at a CAGR of 12.4% over the forecast period. Due to the disease incidences and the need for low-cost drugs, Asia Pacific is the fastest-growing area in the global biopharmaceutical excipients market. This is particularly true in countries like India and China. Several regions are undergoing expansion plans in order to increase manufacturing capacity and quickly scale up drug development standards. China, India, and South Korea, for example, are heavily involved in the production of biosimilars in this area. Affordability, a favourable regulatory environment, cost advantages, and the existence of a vast population base are all factors for the widespread production of biosimilars.

Key Market Players & Competitive Landscape

Some of key players in automated sortation system market are Evonik Industries AG, BASF SE, Akzo Nobel NV, DFE Pharma, Clariant, IMCD, Ferro Corporation, Roquette Frères, Spectrum Chemical Manufacturing Corp., Associated British Foods, among others.

The global Biopharmaceutical Excipients market is segmented as follows:

By Products

  • Specialty Excipients
  • Carbohydrate
  • Polyols
  • Solubilizers & Surfactants/Emulsifiers
  • Others

By Function

  • Lubricants & glidants
  • Preservatives
  • Disintegrants
  • Coatings
  • Binders
  • Pharmaceutical Fillers
  • Others

By Application

  • Advanced Delivery System
  • Parenteral
  • Topical
  • Oral

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter No. 1: Introduction
    • 1.1. Report Description
      • 1.1.1. Purpose of the Report
      • 1.1.2. USP & Key Offerings
    • 1.2. Key Benefits for Stakehulders
    • 1.3. Target Audience
    • 1.4. Report Scope
  • Chapter No. 2: Executive Summary
    • 2.1. Key Findings
      • 2.1.1. Top Investment Pockets
        • 2.1.1.1. Market Attractiveness Analysis, By Products
        • 2.1.1.2. Market Attractiveness Analysis, By Function
        • 2.1.1.3. Market Attractiveness Analysis, By Application
        • 2.1.1.4. Market Attractiveness Analysis, By Region
    • 2.2. Market Snapshot
    • 2.3. Global Biopharmaceutical Excipients Market, 2016 – 2028 (USD Million)
    • 2.4. Insights from Primary Respondents
  • Chapter No. 3: COVID 19 Impact Analysis
    • 3.1. Impact Assessment of COVID-19 Pandemic, By Region
      • 3.1.1. North America
      • 3.1.2. Europe
      • 3.1.3. Asia Pacific
      • 3.1.4. Latin America
      • 3.1.5. The Middle-East and Africa
    • 3.2. Quarterly Market Revenue and Forecast by Region 2020 & 2021
    • 3.3. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Million)
    • 3.4. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Million)
    • 3.5. Key Strategies Undertaken by Companies to Tackle COVID-19
      • 3.5.1. Company Quarterly Revenue Analysis, 2019 & 2020
    • 3.6. Short Term Dynamics
    • 3.7. Long Term Dynamics
  • Chapter No. 4: Biopharmaceutical Excipients Market – Products Segment Analysis
    • 4.1. Overview
      • 4.1.1. Market Revenue Share, By Products, 2020 & 2028
    • 4.2. Specialty Excipients
      • 4.2.1. Market Size and Forecast, By Region (USD Million)
      • 4.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.3. Carbohydrates
      • 4.3.1. Market Size and Forecast, By Region (USD Million)
      • 4.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.3.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.4. Pulyuls
      • 4.4.1. Market Size and Forecast, By Region (USD Million)
      • 4.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.4.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.5. Sulubilizers & Surfactants/Emulsifiers
      • 4.5.1. Market Size and Forecast, By Region (USD Million)
      • 4.5.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.5.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.6. Others
      • 4.6.1. Market Size and Forecast, By Region (USD Million)
      • 4.6.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.6.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 5: Biopharmaceutical Excipients Market – Function Segment Analysis
    • 5.1. Overview
      • 5.1.1. Market Revenue Share, By Function, 2020 & 2028
    • 5.2. lubricants & glidants
      • 5.2.1. Market Size and Forecast, By Region (USD Million)
      • 5.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.3. Preservatives
      • 5.3.1. Market Size and Forecast, By Region (USD Million)
      • 5.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.3.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.4. Disintegrants
      • 5.4.1. Market Size and Forecast, By Region (USD Million)
      • 5.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.4.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.5. Coatings
      • 5.5.1. Market Size and Forecast, By Region (USD Million)
      • 5.5.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.5.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.6. Binders
      • 5.6.1. Market Size and Forecast, By Region (USD Million)
      • 5.6.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.6.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.7. Pharmaceutical Fillers
      • 5.7.1. Market Size and Forecast, By Region (USD Million)
      • 5.7.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.7.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.8. Others
      • 5.8.1. Market Size and Forecast, By Region (USD Million)
      • 5.8.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.8.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 6: Biopharmaceutical Excipients Market – Application Segment Analysis
    • 6.1. Overview
      • 6.1.1. Market Revenue Share, By Application, 2020 & 2028
    • 6.2. Advanced Delivery System
      • 6.2.1. Market Size and Forecast, By Region (USD Million)
      • 6.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 6.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 6.3. Parenteral
      • 6.3.1. Market Size and Forecast, By Region (USD Million)
      • 6.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 6.3.3. Key Market Trends, Growth Factors, & Opportunities
    • 6.4. Topical
      • 6.4.1. Market Size and Forecast, By Region (USD Million)
      • 6.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 6.4.3. Key Market Trends, Growth Factors, & Opportunities
    • 6.5. Oral
      • 6.5.1. Market Size and Forecast, By Region (USD Million)
      • 6.5.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 6.5.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 7: Biopharmaceutical Excipients Market – Regional Analysis
    • 7.1. Overview
      • 7.1.1. Global Market Revenue Share, By Region, 2020 & 2028
      • 7.1.2. Global Market Revenue, By Region, 2016 – 2028 (USD Million)
    • 7.2. North America
      • 7.2.1. North America Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 7.2.2. North America Market Revenue, By Products, 2016 – 2028
      • 7.2.3. North America Market Revenue, By Function, 2016 – 2028
      • 7.2.4. North America Market Revenue, By Application, 2016 – 2028
      • 7.2.5. U.S.
        • 7.2.5.1. U.S. Market Revenue, By Products, 2016 – 2028
        • 7.2.5.2. U.S. Market Revenue, By Function, 2016 – 2028
        • 7.2.5.3. U.S. Market Revenue, By Application, 2016 – 2028
      • 7.2.6. Canada
        • 7.2.6.1. Canada Market Revenue, By Products, 2016 – 2028
        • 7.2.6.2. Canada Market Revenue, By Function, 2016 – 2028
        • 7.2.6.3. Canada Market Revenue, By Application, 2016 – 2028
      • 7.2.7. Mexico
        • 7.2.7.1. Mexico Market Revenue, By Products, 2016 – 2028
        • 7.2.7.2. Mexico Market Revenue, By Function, 2016 – 2028
        • 7.2.7.3. Mexico Market Revenue, By Application, 2016 – 2028
    • 7.3. Europe
      • 7.3.1. Europe Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 7.3.2. Europe Market Revenue, By Products, 2016 – 2028
      • 7.3.3. Europe Market Revenue, By Function, 2016 – 2028
      • 7.3.4. Europe Market Revenue, By Application, 2016 – 2028
      • 7.3.5. Germany
        • 7.3.5.1. Germany Market Revenue, By Products, 2016 – 2028
        • 7.3.5.2. Germany Market Revenue, By Function, 2016 – 2028
        • 7.3.5.3. Germany Market Revenue, By Application, 2016 – 2028
      • 7.3.6. France
        • 7.3.6.1. France Market Revenue, By Products, 2016 – 2028
        • 7.3.6.2. France Market Revenue, By Function, 2016 – 2028
        • 7.3.6.3. France Market Revenue, By Application, 2016 – 2028
      • 7.3.7. U.K.
        • 7.3.7.1. U.K. Market Revenue, By Products, 2016 – 2028
        • 7.3.7.2. U.K. Market Revenue, By Function, 2016 – 2028
        • 7.3.7.3. U.K. Market Revenue, By Application, 2016 – 2028
      • 7.3.8. Italy
        • 7.3.8.1. Italy Market Revenue, By Products, 2016 – 2028
        • 7.3.8.2. Italy Market Revenue, By Function, 2016 – 2028
        • 7.3.8.3. Italy Market Revenue, By Application, 2016 – 2028
      • 7.3.9. Spain
        • 7.3.9.1. Spain Market Revenue, By Products, 2016 – 2028
        • 7.3.9.2. Spain Market Revenue, By Function, 2016 – 2028
        • 7.3.9.3. Spain Market Revenue, By Application, 2016 – 2028
      • 7.3.10. Rest of Europe
        • 7.3.10.1. Rest of Europe Market Revenue, By Products, 2016 – 2028
        • 7.3.10.2. Rest of Europe Market Revenue, By Function, 2016 – 2028
        • 7.3.10.3. Rest of Europe Market Revenue, By Application, 2016 – 2028
    • 7.4. Asia Pacific
      • 7.4.1. Asia Pacific Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 7.4.2. Asia Pacific Market Revenue, By Products, 2016 – 2028
      • 7.4.3. Asia Pacific Market Revenue, By Function, 2016 – 2028
      • 7.4.4. Asia Pacific Market Revenue, By Application, 2016 – 2028
      • 7.4.5. China
        • 7.4.5.1. China Market Revenue, By Products, 2016 – 2028
        • 7.4.5.2. China Market Revenue, By Function, 2016 – 2028
        • 7.4.5.3. China Market Revenue, By Application, 2016 – 2028
      • 7.4.6. Japan
        • 7.4.6.1. Japan Market Revenue, By Products, 2016 – 2028
        • 7.4.6.2. Japan Market Revenue, By Function, 2016 – 2028
        • 7.4.6.3. Japan Market Revenue, By Application, 2016 – 2028
      • 7.4.7. India
        • 7.4.7.1. India Market Revenue, By Products, 2016 – 2028
        • 7.4.7.2. India Market Revenue, By Function, 2016 – 2028
        • 7.4.7.3. India Market Revenue, By Application, 2016 – 2028
      • 7.4.8. South Korea
        • 7.4.8.1. South Korea Market Revenue, By Products, 2016 – 2028
        • 7.4.8.2. South Korea Market Revenue, By Function, 2016 – 2028
        • 7.4.8.3. South Korea Market Revenue, By Application, 2016 – 2028
      • 7.4.9. South-East Asia
        • 7.4.9.1. South-East Asia Market Revenue, By Products, 2016 – 2028
        • 7.4.9.2. South-East Asia Market Revenue, By Function, 2016 – 2028
        • 7.4.9.3. South-East Asia Market Revenue, By Application, 2016 – 2028
      • 7.4.10. Rest of Asia Pacific
        • 7.4.10.1. Rest of Asia Pacific Market Revenue, By Products, 2016 – 2028
        • 7.4.10.2. Rest of Asia Pacific Market Revenue, By Function, 2016 – 2028
        • 7.4.10.3. Rest of Asia Pacific Market Revenue, By Application, 2016 – 2028
    • 7.5. Latin America
      • 7.5.1. Latin America Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 7.5.2. Latin America Market Revenue, By Products, 2016 – 2028
      • 7.5.3. Latin America Market Revenue, By Function, 2016 – 2028
      • 7.5.4. Latin America Market Revenue, By Application, 2016 – 2028
      • 7.5.5. Brazil
        • 7.5.5.1. Brazil Market Revenue, By Products, 2016 – 2028
        • 7.5.5.2. Brazil Market Revenue, By Function, 2016 – 2028
        • 7.5.5.3. Brazil Market Revenue, By Application, 2016 – 2028
      • 7.5.6. Argentina
        • 7.5.6.1. Argentina Market Revenue, By Products, 2016 – 2028
        • 7.5.6.2. Argentina Market Revenue, By Function, 2016 – 2028
        • 7.5.6.3. Argentina Market Revenue, By Application, 2016 – 2028
      • 7.5.7. Rest of Latin America
        • 7.5.7.1. Rest of Latin America Market Revenue, By Products, 2016 – 2028
        • 7.5.7.2. Rest of Latin America Market Revenue, By Function, 2016 – 2028
        • 7.5.7.3. Rest of Latin America Market Revenue, By Application, 2016 – 2028
    • 7.6. The Middle-East and Africa
      • 7.6.1. The Middle-East and Africa Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 7.6.2. The Middle-East and Africa Market Revenue, By Products, 2016 – 2028
      • 7.6.3. The Middle-East and Africa Market Revenue, By Function, 2016 – 2028
      • 7.6.4. The Middle-East and Africa Market Revenue, By Application, 2016 – 2028
      • 7.6.5. GCC Countries
        • 7.6.5.1. GCC Countries Market Revenue, By Products, 2016 – 2028
        • 7.6.5.2. GCC Countries Market Revenue, By Function, 2016 – 2028
        • 7.6.5.3. GCC Countries Market Revenue, By Application, 2016 – 2028
      • 7.6.6. South Africa
        • 7.6.6.1. South Africa Market Revenue, By Products, 2016 – 2028
        • 7.6.6.2. South Africa Market Revenue, By Function, 2016 – 2028
        • 7.6.6.3. South Africa Market Revenue, By Application, 2016 – 2028
      • 7.6.7. Rest of Middle-East Africa
        • 7.6.7.1. Rest of Middle-East Africa Market Revenue, By Products, 2016 – 2028
        • 7.6.7.2. Rest of Middle-East Africa Market Revenue, By Function, 2016 – 2028
        • 7.6.7.3. Rest of Middle-East Africa Market Revenue, By Application, 2016 – 2028
  • Chapter No. 8: Biopharmaceutical Excipients Market – Industry Analysis
    • 8.1. Introduction
    • 8.2. Market Drivers
      • 8.2.1. Driving Factor 1 Analysis
      • 8.2.2. Driving Factor 2 Analysis
    • 8.3. Market Restraints
      • 8.3.1. Restraining Factor Analysis
    • 8.4. Market Opportunities
      • 8.4.1. Market Opportunity Analysis
    • 8.5. Porter’s Five Forces Analysis
    • 8.6. PEST Analysis
    • 8.7. Regulatory Landscape
    • 8.8. Technulogy Landscape
    • 8.9. Regional Market Trends
      • 8.9.1. North America
      • 8.9.2. Europe
      • 8.9.3. Asia Pacific
      • 8.9.4. Latin America
      • 8.9.5. The Middle-East and Africa
    • 8.10. Pricing Analysis
    • 8.11. Value Chain Analysis
    • 8.12. Downstream Buyers
    • 8.13. Distributors/Traders List
  • Chapter No. 9: Competitive Landscape
    • 9.1. Company Market Share Analysis – 2019
      • 9.1.1. Global Biopharmaceutical Excipients Market: Company Market Share, 2019
      • 9.1.2. Global Biopharmaceutical Excipients Market, Company Market Revenue, 2016 – 2019 (USD Million)
      • 9.1.3. Global Biopharmaceutical Excipients Market, Company Y-o-Y Growth, 2017 – 2019 (%)
      • 9.1.4. Global Biopharmaceutical Excipients Market: Radar Determinant Chart, 2019
    • 9.2. Strategic Developments
      • 9.2.1. Acquisitions & Mergers
      • 9.2.2. New Product Launch
      • 9.2.3. Regional Expansion
    • 9.3. Company Strategic Developments – Heat Map Analysis
  • Chapter No. 10: Company Profiles
    • 10.1. Evonik Industries AG
      • 10.1.1. Company Overview
      • 10.1.2. Key Executives
      • 10.1.3. Product Portfulio
      • 10.1.4. Financial Overview
      • 10.1.5. Operating Business Segments
      • 10.1.6. Business Performance
      • 10.1.7. Recent Developments
    • 10.2. BASF SE
    • 10.3. Akzo Nobel NV
    • 10.4. DFE Pharma
    • 10.5. Clariant
    • 10.6. IMCD
    • 10.7. Ferro Corporation
    • 10.8. Roquette Frères
    • 10.9. Spectrum Chemical Manufacturing Corp.
    • 10.10. Associated British Foods
  • Chapter No. 11: Marketing Strategy Analysis
    • 11.1. Marketing Channel
    • 11.2. Direct Marketing
    • 11.3. Indirect Marketing
    • 11.4. Marketing Channel Development Trends
    • 11.5. Economic/Pulitical Environmental Change
  • Chapter No. 12: Research Methodulogy
    • 12.1. Research Methodulogy
    • 12.2. Phase I - Secondary Research
    • 12.3. Phase II - Data Modeling
      • 12.3.1. Company Share Analysis Model
      • 12.3.2. Revenue Based Modeling
    • 12.4. Phase III - Primary Research
    • 12.5. Research Limitations
      • 12.5.1. Assumptions

Methodology


Frequently Asked Questions

The global Biopharmaceutical Excipients market was valued at USD 2.07 Billion in 2020.
The global Biopharmaceutical Excipients market is expected to reach USD 3.97 Billion by 2028, growing at a CAGR of 8.5% between 2021 to 2028.
Some of the key factors driving the global Biopharmaceutical Excipients market growth are Supreme Properties of Biopharmaceutical Excipients and Need for Improved Drug Delivery.

North America region held a substantial share of the Biopharmaceutical Excipients market in 2020. Asia Pacific is the fastest-growing area in the global biopharmaceutical excipients market. Several regions are undergoing expansion plans in order to increase manufacturing capacity and quickly scale up drug development standards. China, India, and South Korea, for example, are heavily involved in the production of biosimilars in this area.

Some of the major companies operating in the Biopharmaceutical Excipients market are Evonik Industries AG, BASF SE, Akzo Nobel NV, DFE Pharma, Clariant, IMCD, Ferro Corporation, Roquette Frères, Spectrum Chemical Manufacturing Corp., Associated British Foods, among others.
}
Office Address

Corporate Office
Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office
3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #
US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com